PRESS RELEASE

Q2 2024 — Press release

Q2 2024PDF · 8 pages356 KB
Media contact 	Investor contact
Laurie Bischel, 312.648.8698 	Adam Minick, 312.340.8365
Timothy Barello, 212.299.2256 	investors@cmegroup.com
news@cmegroup.com 	CME-G
cmegroup.mediaroom.com
FOR IMMEDIATE RELEASE
CME Group Inc. Reports All-Time Record Revenue of $1.5 Billion for Q2 2024
• 	Record quarterly adjusted net income and earnings per share
• 	Highest Q2 average daily volume (ADV) in company history (26 million
contracts)
• 	Year-over-year growth across every asset class
CHICAGO, July 24, 2024 - CME Group Inc. (NASDAQ: CME) today reported financial
results for the second quarter of 2024.
The company reported revenue of $1.5 billion and operating income of $1.0 billion for
the second quarter of 2024. Net income was $883 million and diluted earnings per common
share were $2.42. On an adjusted basis, net income was $932 million and diluted earnings per
common share were $2.56. Financial results presented on an adjusted basis for the second
quarter of 2024 and 2023 exclude certain items, which are detailed in the reconciliation of non-
GAAP results. 1
"As escalating uncertainties drove an increased need for risk management across all
asset classes, CME Group achieved record Q2 volume and generated record revenue, adjusted
net income and adjusted earnings per share," said CME Group Chairman and Chief Executive
Officer Terry Duffy. "During the quarter, and for the first time in more than a decade, our volume
and open interest grew in every asset class, with overall ADV up 16% in commodities and 13%
in financial markets. We also reached significant records in many of our U.S. Treasury products
where ADV increased 36% to 8.2 million contracts."
"As we move through the remainder of 2024, we will continue to focus on delivering
capital efficiencies, bringing new products to market and creating additional value for our clients
through our partnership with Google Cloud."
Second-quarter 2024 average daily volume (ADV) was 25.9 million contracts, including
non-U.S. ADV, which reached a record 7.8 million contracts.
1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the
Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation materials.
- more –

-- 1 of 8 --

Page 2
Clearing and transaction fees revenue for second-quarter 2024 totaled $1.2 billion. The
total average rate per contract was $0.708. Market data revenue totaled $175 million for
second-quarter 2024.
As of June 30, 2024, the company had approximately $2.0 billion in cash (including $225
million deposited with Fixed Income Clearing Corporation, which is included in other current
assets) and $3.4 billion of debt. The company paid dividends during the second quarter of
approximately $419 million. The company has returned approximately $25.2 billion to
shareholders in the form of dividends since the implementation of the variable dividend policy in
early 2012.
CME Group will hold a Q&A conference call to discuss second-quarter 2024
results at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be
available on the Investor Relations section of CME Group's website at
investor.cmegroup.com under Events & Presentations. An archived recording will be
available for up to two months after the call.
As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients
to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering
market participants worldwide to efficiently manage risk and capture opportunities. CME Group
exchanges offer the widest range of global benchmark products across all major asset classes based on
interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company
offers futures and options on futures trading through the CME Globex platform, fixed income trading via
BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's
leading central counterparty clearing providers, CME Clearing.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are
trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of
Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are
trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc.
BrokerTec and EBS are trademarks of BrokerTec Europe LTD and EBS Group LTD, respectively. The
S&P 500 Index is a product of S&P Dow Jones Indices LLC (“S&P DJI”). “S&P®”, “S&P 500®”, “SPY®”,
“SPX®”, US 500 and The 500 are trademarks of Standard & Poor’s Financial Services LLC; Dow Jones®,
DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark
Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc.
Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by
S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products.
All other trademarks are the property of their respective owners.
- more –

-- 2 of 8 --

Page 3
Statements in this press release that are not historical facts are forward-looking statements. These
statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are
difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied
in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking
statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of
new information, future events or otherwise. Among the factors that might affect our performance are increasing
competition by foreign and domestic entities, including increased competition from new entrants into our markets
and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our
ability to complete the development, implementation and maintenance of the enhanced functionality required by
our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our
ability to continue introducing competitive new products and services on a timely, cost-effective basis, including
through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products
and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to maintain
existing customers at substantially similar trading levels, develop strategic relationships and attract new customers;
our ability to expand and globally offer our products and services; changes in regulations, including the impact of
any changes in laws or government policies with respect to our products or services or our industry, such as any
changes to regulations and policies that require increased financial and operational resources from us or our
customers; the costs associated with protecting our intellectual property rights and our ability to operate our
business without violating the intellectual property rights of others; decreases in revenue from our market data as a
result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due
to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer
receives member or non-member fees or participates in one of our various incentive programs) and the impact of
our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect
us from the credit risks of clearing members and other counterparties, and to satisfy the margin and liquidity
requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk
management programs to effectively monitor and manage our risks, including our ability to prevent errors and
misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual
property assets; our dependence on third-party providers and exposure to risk through third parties, including risks
related to the performance, reliability and security of technology used by our third-party providers and third-party
providers that our clients rely on; volatility in commodity, equity and fixed income prices, and price volatility of
financial benchmarks and instruments such as interest rates, equity indices, fixed income instruments and foreign
exchange rates; economic, social, political and market conditions, including the volatility of the capital and credit
markets and the impact of economic conditions on the trading activity of our current and potential customers; our
ability to accommodate increases in contract volume and order transaction traffic and to implement enhancements
without failure or degradation of the performance of our trading and clearing systems; our ability to execute our
growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs and achieve
the synergies associated with our strategy for acquisitions, investments and alliances, including those associated
with the performance of our joint ventures with S&P Dow Jones (S&P Dow Jones Indices LLC) in index services and in
trade processing/post trade services (OSTTRA), our primary business and distribution partners’ actions and our
partnership with Google Cloud; variances in earnings on cash accounts and collateral that our clearing house holds
for its clients; impact of CME Group pricing and incentive changes; impact of aggregation services and
internalization on trade flow and volumes; any negative financial impacts from changes to the terms of intellectual
property and index rights; our ability to continue to generate funds and/or manage our indebtedness to allow us to
continue to invest in our business; industry, channel partner and customer consolidation and/or concentration;
decreases in trading and clearing activity; the imposition of a transaction tax or user fee on futures and options
transactions and/or repeal of the 60/40 tax treatment of such transactions; increases in effective tax rates,

-- 3 of 8 --

Page 4
borrowing costs, or changes in tax policy; our ability to maintain our brand and reputation; and the unfavorable
resolution of material legal proceedings. For a detailed discussion and additional information concerning these and
other factors that might affect our performance, see our other recent periodic filings, including our Annual Report
on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission ("SEC")
on February 28, 2024, under the caption "Risk Factors".
# # #
24-57

-- 4 of 8 --

CME Group Inc. and Subsidiaries
Consolidated Balance Sheets
(in millions)
June 30, 2024 	December 31, 2023
ASSETS
Current Assets:
Cash and cash equivalents 	$ 	1,789.9 	$ 	2,912.0
Marketable securities 	121.7 	111.7
Accounts receivable, net of allowance 	599.5 	535.6
Other current assets (includes $5.2 in restricted cash) 	567.5 	1,138.4
Performance bonds and guaranty fund contributions 	85,670.0 	90,192.5
Total current assets 	88,748.6 	94,890.2
Property, net of accumulated depreciation and amortization 	384.5 	409.5
Intangible assets—trading products 	17,175.3 	17,175.3
Intangible assets—other, net 	2,932.5 	3,050.2
Goodwill 	10,488.6 	10,495.3
Other assets 	3,649.8 	3,685.6
Total Assets 	$ 	123,379.3 	$ 	129,706.1
LIABILITIES AND EQUITY
Current Liabilities:
Accounts payable 	$ 	99.9 	$ 	90.6
Short-term debt 	749.5 	—
Other current liabilities 	454.6 	3,133.8
Performance bonds and guaranty fund contributions 	85,670.0 	90,192.5
Total current liabilities 	86,974.0 	93,416.9
Long-term debt 	2,677.2 	3,425.4
Deferred income tax liabilities, net 	5,309.1 	5,327.7
Other liabilities 	783.2 	798.2
Total Liabilities 	95,743.5 	102,968.2
Total CME Group Shareholders’ Equity 	27,635.8 	26,737.9
Total Liabilities and Equity 	$ 	123,379.3 	$ 	129,706.1

-- 5 of 8 --

CME Group Inc. and Subsidiaries
Consolidated Statements of Income
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
June 30,
Six Months Ended
June 30,
2024 	2023 	2024 	2023
Revenues
Clearing and transaction fees 	$ 	1,249.9 	$ 	1,118.3 	$ 2,458.8 	$ 2,318.5
Market data and information services 	175.0 	163.1 	350.4 	328.9
Other 	107.6 	78.8 	211.2 	154.4
Total Revenues 	1,532.5 	1,360.2 	3,020.4 	2,801.8
Expenses
Compensation and benefits 	204.7 	205.7 	410.7 	410.2
Technology 	64.1 	53.3 	123.5 	104.6
Professional fees and outside services 	34.7 	37.8 	67.8 	76.1
Amortization of purchased intangibles 	55.5 	57.0 	110.7 	113.8
Depreciation and amortization 	28.7 	32.3 	58.8 	64.2
Licensing and other fee agreements 	85.9 	78.2 	173.8 	162.9
Other 	58.3 	57.3 	114.9 	117.7
Total Expenses 	531.9 	521.6 	1,060.2 	1,049.5
Operating Income 	1,000.6 	838.6 	1,960.2 	1,752.3
Non-Operating Income (Expense)
Investment income 	1,044.5 	1,568.2 	2,115.8 	2,925.9
Interest and other borrowing costs 	(40.1) 	(40.2) 	(80.0) 	(80.1)
Equity in net earnings of unconsolidated subsidiaries 	86.4 	75.1 	173.6 	153.3
Other non-operating income (expense) 	(936.9) 	(1,425.3) 	(1,901.7) 	(2,578.1)
Total Non-Operating Income (Expense) 	153.9 	177.8 	307.7 	421.0
Income before Income Taxes 	1,154.5 	1,016.4 	2,267.9 	2,173.3
Income tax provision 	271.3 	238.8 	529.5 	511.9
Net Income 	$ 	883.2 	$ 	777.6 	$ 1,738.4 	$ 1,661.4
Net Income Attributable to Common Shareholders of CME
Group 	$ 	872.1 	$ 	767.8 	$ 1,716.5 	$ 1,640.5
Earnings per Share Attributable to Common Shareholders of
CME Group:
Basic 	$ 	2.43 	$ 	2.14 	$ 	4.78 	$ 	4.57
Diluted 	2.42 	2.14 	4.77 	4.56
Weighted Average Number of Common Shares:
Basic 	359,330 	358,940 	359,294 	358,937
Diluted 	359,869 	359,429 	359,852 	359,371

-- 6 of 8 --

CME Group Inc. and Subsidiaries
Quarterly Operating Statistics
2Q 2023 	3Q 2023 	4Q 2023 	1Q 2024 	2Q 2024
Trading Days 	62 	63 	63 	61 	63
Quarterly Average Daily Volume (ADV)(1)
CME Group ADV (in thousands)
Product Line 	2Q 2023 	3Q 2023 	4Q 2023 	1Q 2024 	2Q 2024
Interest rates 	11,273 	10,967 	13,348 	13,839 	12,894
Equity indexes 	6,216 	6,353 	6,922 	6,856 	6,779
Foreign exchange 	898 	942 	1,007 	984 	1,075
Energy 	2,104 	2,126 	2,158 	2,412 	2,447
Agricultural commodities 	1,752 	1,433 	1,469 	1,596 	1,877
Metals 	612 	528 	609 	675 	868
Total 	22,855 	22,349 	25,513 	26,360 	25,941
Venue
CME Globex 	20,907 	20,838 	23,503 	23,985 	24,143
Open outcry 	1,124 	713 	1,126 	1,333 	825
Privately negotiated 	825 	797 	885 	1,043 	974
Total 	22,855 	22,349 	25,513 	26,360 	25,941
Quarterly Average Rate Per Contract (RPC)(1)
CME Group RPC
Product Line 	2Q 2023 	3Q 2023 	4Q 2023 	1Q 2024 	2Q 2024
Interest rates 	$ 	0.505 	$ 	0.508 	$ 	0.488 	$ 	0.486 	$ 	0.484
Equity indexes 	0.644 	0.625 	0.616 	0.641 	0.628
Foreign exchange 	0.800 	0.791 	0.806 	0.787 	0.754
Energy 	1.347 	1.324 	1.338 	1.334 	1.297
Agricultural commodities 	1.356 	1.328 	1.361 	1.356 	1.366
Metals 	1.487 	1.492 	1.502 	1.556 	1.511
Average RPC 	$ 	0.724 	$ 	0.707 	$ 	0.682 	$ 	0.695 	$ 	0.708
1. ADV and RPC includes futures and options on futures only.

-- 7 of 8 --

CME Group Inc. and Subsidiaries
Reconciliation of GAAP to non-GAAP Measures
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
June 30,
Six Months Ended
June 30,
2024 	2023 	2024 	2023
Net Income 	$ 	883.2 	$ 	777.6 	$ 1,738.4 	$ 1,661.4
Restructuring and severance 	0.8 	1.6 	3.6 	2.3
Amortization of purchased intangibles(1) 	68.9 	70.5 	137.6 	140.6
Strategic transaction-related costs (credits) 	(1.1) 	— 	0.8 	(2.2)
Real estate-related costs (credits) 	(1.0) 	— 	(1.0) 	—
Foreign exchange transaction (gains) losses 	(0.3) 	1.1 	(2.1) 	1.8
Unrealized and realized (gains) losses on investments 	(9.2) 	1.0 	(11.7) 	(73.8)
Unrealized and realized (gains) losses on assets 	— 	0.4 	0.8 	0.4
Income tax effect related to above 	(11.0) 	(15.0) 	(25.0) 	(11.0)
Other income tax items 	1.9 	(0.8) 	1.9 	(0.8)
Adjusted Net Income 	$ 	932.2 	$ 	836.4 	$ 1,843.3 	$ 1,718.7
Adjusted Net Income Attributable to Common Shareholders of CME
Group 	$ 	920.4 	$ 	825.9 	$ 1,820.1 	$ 1,697.0
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic 	$ 	2.43 	$ 	2.14 	$ 	4.78 	$ 	4.57
Diluted 	2.42 	2.14 	4.77 	4.56
Adjusted Earnings per Share Attributable to Common Shareholders of CME Group:
Basic 	$ 	2.56 	$ 	2.30 	$ 	5.07 	$ 	4.73
Diluted 	2.56 	2.30 	5.06 	4.72
Weighted Average Number of Common Shares:
Basic 	359,330 	358,940 	359,294 	358,937
Diluted 	359,869 	359,429 	359,852 	359,371
Preferred shares(2) 	4,584 	4,584 	4,584 	4,584
1. Includes $11.1 million of amortization of purchased intangibles (net of tax) at OSTTRA and $2.4 million of amortization of
purchased intangibles at S&P Dow Jones Indices LLC, reported in Equity in net earnings of unconsolidated subsidiaries on the
Consolidated Statements of Income.
2. Preferred shares have similar rights as common shares without voting rights.

-- 8 of 8 --